Yonsei University: Dyslipidemias trials
The registry lists 14 Dyslipidemias studies with Yonsei University as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 4 8No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVDRecruitingNCT07524101Not applicable
- Effect of Ezetimibe on Gut MicrobiotaRecruitingNCT06784557Phase 4
- Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney DiseaseRecruitingNCT06322056Not applicable
- Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With DyslipidemiaRecruitingNCT06153433Phase 4
- Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized TrialRecruitingNCT05705804Not applicable
- Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)Active, not recruitingNCT05910476Phase 4
- Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE TrialCompletedNCT04626973Not applicable
- Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and DyslipidemiaCompletedNCT04061824Phase 4
- Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism EventCompletedNCT03988101Phase 4
- Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic PatientsCompletedNCT03949374Phase 4
- Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With DyslipidemiaCompletedNCT03730038Not applicable
- Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver DiseaseCompletedNCT03434613Phase 4
- Metagenomic Analysis of Human Gut Microbiota in Patients With Metabolic Diseases Including DiabetesStatus unknownNCT03204799
- Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting StentsCompletedNCT01502904Phase 4